Zobrazeno 1 - 10
of 148
pro vyhledávání: '"K Midthun"'
Autor:
W. P. McKinney, K. Midthun, R. D. Clover, C. Heilman, Kristin L Nichol, Jr Snider, J. E. Cheek, D. Bradshaw, L. D. Rotz, H. D. Wilson, C. T. Le, D. A. Brooks, D. A. Ashford, M. B. Rennels, G. Peter, R. E. Jackson, J. Abramson, J. I. Santos, V. Marchessault, L. Pickering, B. M. Word, S. A. Gall, L. S. Tompkins, F. A. Guerra, John F. Modlin, T. R. Graydon, M. Mahoney, J. D. Siegel, C. M. Helms, G. S. Evans, M. G. Myers, D. R. Johnson, B. J. Howe, S. L. Katz, P. Gardner, P. A. Offit, W. Schaffner
Publikováno v:
Journal of Toxicology: Clinical Toxicology. 39:85-100
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In add
Autor:
Peter F. Wright, Ellen Sperber, Ruth A. Karron, K Midthun, Jacek Mrukowicz, Mamodikoe K. Makhene, Albert Z. Kapikian, Mary Lou Clements-Mann, Yasutaka Hoshino
Publikováno v:
Vaccine. 17:2715-2725
Live rotavirus vaccine candidates representing VP7 serotypes 1, 2, 3 or 4 derived by reassortment between bovine UK rotavirus and human rotavirus strains D, DS-1, P or ST3 were evaluated for safety and immunogenicity in adults, children and infants.
Autor:
Mehmet Ceyhan, Edward T. Zito, K Midthun, Güler Kanra, Gülten Seçmeer, Bruce Davidson, Timo Vesikari
Publikováno v:
Acta Paediatrica. 82:223-227
Rhesus-human reassortant tetravalent rotavirus vaccine at a titer of 4 x 10(4) plaque forming units was evaluated for immunogenicity in 194 6-8-week-old breast-fed Turkish infants. The vaccine was administered orally as a single dose following either
Autor:
R B Belshe, Raphael Dolin, K Midthun, Mary Lou Clements, Geoffrey J. Gorse, Peter F. Wright, Barney S. Graham, Norbert J. Roberts, Michael C. Keefer, Lawrence Corey
Publikováno v:
Journal of Infectious Diseases. 166:244-252
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) gp160 recombinant vaccinia virus (HIVAC-1e) vaccine was evaluated in vaccinia-naive, healthy adults at low risk for acquiring HIV-1 infection. Volunteers (n = 36) were ran
Autor:
Gary B. Calandra, David R. Nalin, Philip J. Provost, Edward F. Ellerbeck, Audrey E. Rhoad, John A. Lewis, Brenda McGuire, Kenneth Gershman, K Midthun, William J. Miller, Joseph P. Davide, Marcy E. Armstrong
Publikováno v:
Vaccine. 10:668-672
To determine the safety and immunogenicity of an inactivated hepatitis A vaccine, 56 healthy adult volunteers were randomly assigned to receive an intramuscular injection of 6.3, 12.5 or 25 ng of inactivated hepatitis A vaccine or placebo at 0, 2 or
Publikováno v:
Developments in biologicals. 116
Preventive vaccines for infectious disease indications are regulated by the Office of Vaccines Research and Review, CBER, FDA. FDA-regulated biological products, including vaccines, must be safe, pure, potent, and manufactured consistently according
Autor:
M L, Clements-Mann, M K, Makhene, J, Mrukowicz, P F, Wright, Y, Hoshino, K, Midthun, E, Sperber, R, Karron, A Z, Kapikian
Publikováno v:
Vaccine. 17(20-21)
Live rotavirus vaccine candidates representing VP7 serotypes 1, 2, 3 or 4 derived by reassortment between bovine UK rotavirus and human rotavirus strains D, DS-1, P or ST3 were evaluated for safety and immunogenicity in adults, children and infants.
Publikováno v:
Developments in biological standardization. 95
The development plan for new combination vaccines should include clinical studies designed to provide an adequate safety database (as well as efficacy data) to support licensure. Ideally, randomized studies to compare the safety of the combination va
Autor:
B S, Graham, R B, Belshe, M L, Clements, R, Dolin, L, Corey, P F, Wright, G J, Gorse, K, Midthun, M C, Keefer, N J, Roberts
Publikováno v:
The Journal of infectious diseases. 166(2)
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) gp160 recombinant vaccinia virus (HIVAC-1e) vaccine was evaluated in vaccinia-naive, healthy adults at low risk for acquiring HIV-1 infection. Volunteers (n = 36) were ran
Autor:
Victoria Perkis, Albert Z. Kapikian, Mark C. Steinhoff, K Midthun, Mary Lou Clements, Ruth A. Karron, Mary Jett-Goheen, James King, Barbara J. Burns, Roberta Samorodin, Neal A. Halsey, Modena E. H. Wilson
Publikováno v:
The Journal of infectious diseases. 164(4)
Rotavirus vaccine strain M37 (serotype 1), recovered from the stool of an asymptomatic newborn infant and serially passaged in cell culture, was given orally to adults, children, and infants. Serologic responses were detected by neutralization assay